Anavex Life Sciences
AVXL
#7563
Rank
A$0.59 B
Marketcap
A$6.62
Share price
-1.12%
Change (1 day)
-43.78%
Change (1 year)

Anavex Life Sciences (AVXL) - Total assets

Total assets on the balance sheet as of June 2025 : A$0.15 Billion

According to Anavex Life Sciences 's latest financial reports the company's total assets are A$0.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Anavex Life Sciences - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-09-30A$0.19 B-18.38%
2023-09-30A$0.24 B1.16%
2022-09-30A$0.23 B6.23%
2021-09-30A$0.22 B363.7%
2020-09-30A$48.19 M28.51%
2019-09-30A$37.5 M3.39%
2018-09-30A$36.27 M2.24%
2017-09-30A$35.48 M185.32%
2016-09-30A$12.43 M-43.65%
2015-09-30A$22.06 M162.21%
2014-09-30A$8.41 M1893.71%
2013-09-30A$0.42 M3223.45%
2012-09-30A$0.01 M-93.91%
2011-09-30A$0.2 M-39.06%
2010-09-30A$0.34 M-27.32%
2009-09-30A$0.47 M5063.79%
2008-09-30A$0 M32500.1%
2007-09-30A$0 M-99.83%
2006-09-30A$0.01 M1201.97%
2005-09-30A$0 M-96.72%
2004-09-30A$0.03 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ligand Pharmaceuticals
LGND
A$2.22 B 1,341.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.67 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$1.23 B 704.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$5.61 M-96.36%๐Ÿ‡บ๐Ÿ‡ธ USA